文献速递胃肠外科急腹症与外科感染围术期管理与 ERAS

血清与脂肪组织头孢美唑浓度与下消化道手术部位感染的关系

Association of serum and fat tissue antibiotic concentrations with surgical site infections in lower gastrointestinal surgery.
PubMed 文献 · Surgery · 2021-11-10

本前瞻性队列研究在单一三级医疗中心纳入2017年10月至2019年9月接受结直肠手术的105例患者,测定头孢美唑在血清、皮下脂肪及肠系膜脂肪组织的浓度。手术部位感染发生率为13/105(12.4%)。单因素分析中,皮肤缝合时皮下脂肪组织头孢美唑浓度是手术部位感染的显著危险因素。

要点

  • 结直肠手术部位感染发生率为13/105(12.4%)
  • 皮肤缝合时皮下脂肪组织头孢美唑浓度是手术部位感染的显著危险因素
  • 年龄、术中追加头孢美唑及肌酐清除率亦为显著危险因素

核心结论

  • 胃肠手术皮肤缝合时皮下脂肪头孢美唑浓度偏低可能与手术部位感染的发生有关。

研究设计与样本

  • 前瞻性队列研究,在单一三级医疗中心开展,纳入2017年10月至2019年9月接受结直肠手术的105例患者,主要结局为手术部位感染发生率。

主要发现

  • 手术部位感染发生率为13/105(12.4%)。
  • 初次切开时头孢美唑浓度:血清101 vs 93.1 mg/L(P = .75),皮下脂肪组织2.8 vs 3.7 mg/g(P = .15)。
  • 肠管切除时头孢美唑浓度:血清35.1 vs 36.7 mg/L(P = .63),肠系膜脂肪组织1.3 vs 1.7 mg/g(P = .55)。
  • 皮肤缝合时头孢美唑浓度:血清34.5 vs 44.8 mg/L(P = .18),皮下脂肪组织1.0 vs 2.2 mg/g(P = .09)。
  • 以P ≤ .10行单因素分析,皮肤缝合时皮下脂肪组织头孢美唑浓度、年龄、术中追加头孢美唑及肌酐清除率均为手术部位感染的显著危险因素。

关键数值与推荐

  • 单因素分析采用P ≤ .10筛选变量,皮肤缝合时皮下脂肪组织头孢美唑浓度为手术部位感染的显著危险因素。
  • 皮肤缝合时皮下脂肪组织头孢美唑浓度1.0 vs 2.2 mg/g(P = .09),血清34.5 vs 44.8 mg/L(P = .18)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: During surgery, the effectiveness of perioperative prophylactic antibiotic administration against surgical site infections is inferred from serum concentrations and not from tissues where local infections occur. This study aimed to measure the serum and tissue concentrations of cefmetazole in colorectal surgery cases to clarify whether there is an association between the incidence of surgical site infections and antibiotic concentrations. METHODS: This prospective cohort study was performed at a single tertiary care center. The data of 105 patients who underwent colorectal surgery between October 2017 and September 2019 were evaluated. The primary outcome was the incidence of surgical site infections. Univariate analysis was performed to investigate the association between surgical site infections, perioperative factors, and the serum and tissue concentrations of cefmetazole. RESULTS: The incidence of surgical site infections was 13/105 (12.4%). Cefmetazole concentrations were measured at initial incision (serum; 101 vs 93.1 mg/L, P = .75, subcutaneous fat tissue; 2.8 vs 3.7 mg/g, P = .15), intestinal resection (serum; 35.1 vs 36.7 mg/L, P = .63, mesenteric adipose tissue; 1.3 vs 1.7 mg/g, P = .55), and at skin closure (serum; 34.5 vs 44.8 mg/L, P = .18, subcutaneous fat tissue; 1.0 vs 2.2 mg/g, P = .09). In univariate analysis with P ≤ .10, cefmetazole concentration in subcutaneous fat tissue at skin closure was found to be a significant risk factor for surgical site infections. Age, additional intraoperative administration of cefmetazole, and creatinine clearance were also significant risk factors for the occurrence of surgical site infections. CONCLUSION: Low subcutaneous fat cefmetazole concentrations at skin closure during gastrointestinal operations may also be involved in the occurrence of surgical site infections.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Takayama Y, Komatsu T, Nakamura T, et al. Association of serum and fat tissue antibiotic concentrations with surgical site infections in lower gastrointestinal surgery. Surgery. 2021. PMID: 34772516. doi:10.1016/j.surg.2021.10.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。